_version_ |
1826289798258622464
|
author |
Fairbank, J
|
author_facet |
Fairbank, J
|
author_sort |
Fairbank, J
|
collection |
OXFORD
|
description |
|
first_indexed |
2024-03-07T02:34:23Z
|
format |
Journal article
|
id |
oxford-uuid:a84c79b0-d4b8-4d3b-a41d-3c28d5e5ebd6
|
institution |
University of Oxford
|
language |
English
|
last_indexed |
2024-03-07T02:34:23Z
|
publishDate |
2007
|
record_format |
dspace
|
spelling |
oxford-uuid:a84c79b0-d4b8-4d3b-a41d-3c28d5e5ebd62022-03-27T03:00:31ZRe: Zigler J, Delamarter R, Spivak J, et al. Results of the prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement versus circumferential fusion for the treatment of 1-level degenerative disc disease. Spine 2007;32:1155-62.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:a84c79b0-d4b8-4d3b-a41d-3c28d5e5ebd6EnglishSymplectic Elements at Oxford2007Fairbank, J
|
spellingShingle |
Fairbank, J
Re: Zigler J, Delamarter R, Spivak J, et al. Results of the prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement versus circumferential fusion for the treatment of 1-level degenerative disc disease. Spine 2007;32:1155-62.
|
title |
Re: Zigler J, Delamarter R, Spivak J, et al. Results of the prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement versus circumferential fusion for the treatment of 1-level degenerative disc disease. Spine 2007;32:1155-62.
|
title_full |
Re: Zigler J, Delamarter R, Spivak J, et al. Results of the prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement versus circumferential fusion for the treatment of 1-level degenerative disc disease. Spine 2007;32:1155-62.
|
title_fullStr |
Re: Zigler J, Delamarter R, Spivak J, et al. Results of the prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement versus circumferential fusion for the treatment of 1-level degenerative disc disease. Spine 2007;32:1155-62.
|
title_full_unstemmed |
Re: Zigler J, Delamarter R, Spivak J, et al. Results of the prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement versus circumferential fusion for the treatment of 1-level degenerative disc disease. Spine 2007;32:1155-62.
|
title_short |
Re: Zigler J, Delamarter R, Spivak J, et al. Results of the prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement versus circumferential fusion for the treatment of 1-level degenerative disc disease. Spine 2007;32:1155-62.
|
title_sort |
re zigler j delamarter r spivak j et al results of the prospective randomized multicenter food and drug administration investigational device exemption study of the prodisc l total disc replacement versus circumferential fusion for the treatment of 1 level degenerative disc disease spine 2007 32 1155 62
|
work_keys_str_mv |
AT fairbankj reziglerjdelamarterrspivakjetalresultsoftheprospectiverandomizedmulticenterfoodanddrugadministrationinvestigationaldeviceexemptionstudyoftheprodiscltotaldiscreplacementversuscircumferentialfusionforthetreatmentof1leveldegenerativediscdiseasespine200732115
|